Carter King
EVP, Business Development Protagonist Therapeutics, Inc.
Seminars
- Revisiting the history of the program from inception to initial approval
- Presenting an overview of the collaboration Johnson & Johnson, including amendments
- Showcasing a competitive landscape & comparative data (efficacy/safety)
- Highlighting the next wave of peptide therapeutics